Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
37.85
79.22
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Hangzhou Tigermed Consulting Co Ltd stock under the Base Case scenario is 70.35 CNY. Compared to the current market price of 60.98 CNY, Hangzhou Tigermed Consulting Co Ltd is Undervalued by 13%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Hangzhou Tigermed Consulting Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Hangzhou Tigermed Consulting Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Hangzhou Tigermed Consulting Co., Ltd. is a leading clinical trial and consulting organization based in China, dedicated to facilitating the development of innovative medical therapies. Founded in 2002, the company has rapidly ascended to prominence by leveraging its deep expertise in clinical research while providing comprehensive services that encompass all phases of clinical trials. With a robust portfolio that includes over 4,000 completed projects, Tigermed stands out for its strong focus o...
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Hangzhou Tigermed Consulting Co Ltd
Balance Sheet Decomposition
Hangzhou Tigermed Consulting Co Ltd
Current Assets | 7.6B |
Cash & Short-Term Investments | 3.2B |
Receivables | 4.3B |
Other Current Assets | 150.1m |
Non-Current Assets | 22.8B |
Long-Term Investments | 17.7B |
PP&E | 1.5B |
Intangibles | 3.1B |
Other Non-Current Assets | 363.9m |
Current Liabilities | 5.3B |
Accounts Payable | 227.1m |
Accrued Liabilities | 346m |
Short-Term Debt | 2.8B |
Other Current Liabilities | 2B |
Non-Current Liabilities | 4.3B |
Long-Term Debt | 791.6m |
Other Non-Current Liabilities | 3.5B |
Earnings Waterfall
Hangzhou Tigermed Consulting Co Ltd
Revenue
|
6.8B
CNY
|
Cost of Revenue
|
-4.3B
CNY
|
Gross Profit
|
2.5B
CNY
|
Operating Expenses
|
-1.2B
CNY
|
Operating Income
|
1.4B
CNY
|
Other Expenses
|
-400.3m
CNY
|
Net Income
|
958.7m
CNY
|
Free Cash Flow Analysis
Hangzhou Tigermed Consulting Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Hangzhou Tigermed Consulting Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Hangzhou Tigermed Consulting Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Hangzhou Tigermed Consulting Co Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Score
Hangzhou Tigermed Consulting Co Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Hangzhou Tigermed Consulting Co Ltd
According to Wall Street analysts, the average 1-year price target for Hangzhou Tigermed Consulting Co Ltd is 63.51 CNY with a low forecast of 35.35 CNY and a high forecast of 90.2 CNY.
Dividends
Current shareholder yield for Hangzhou Tigermed Consulting Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Hangzhou Tigermed Consulting Co Ltd stock under the Base Case scenario is 70.35 CNY.
Compared to the current market price of 60.98 CNY, Hangzhou Tigermed Consulting Co Ltd is Undervalued by 13%.